This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nu Skin (NUS) Down 5.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Splunk (SPLK) Incurs Loss in Q3 Earnings, Revenues Down Y/Y
by Zacks Equity Research
Splunk's (SPLK) third-quarter fiscal 2021 results reflect growth in cloud revenues and customer base expansion despite decline in license revenues.
Estee Lauder (EL) Gains on Solid Online Business & Savings
by Zacks Equity Research
Estee Lauder (EL) is benefiting from its robust e-commerce business, especially amid the COVID-19 outbreak. Also, its solid presence in emerging markets is impressive.
Helen of Troy Limited (HELE) Gains on Robust Online Business
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from its robust e-commerce business, especially amid COVID-19. Also, strength in its Leadership Brands is yielding.
Zacks.com featured highlights include: TeleTech, Thermo Fisher, Best Buy, ParkerHannifin and Nu Skin
by Zacks Equity Research
Zacks.com featured highlights include: TeleTech, Thermo Fisher, Best Buy, ParkerHannifin and Nu Skin
Nu Skin (NUS) Looks Radiant on Innovation & Digital Strength
by Zacks Equity Research
Nu Skin (NUS) has been gaining on initiatives to strengthen sales leader and expand customer base through product launches. Also, the company's focus on digital operations bodes well.
Is Colgate (CL) Benefiting From Healthy Consumer Good Demand?
by Zacks Equity Research
Colgate (CL) benefits from the increase in demand for personal and home care products due to the pandemic-led increase in hygiene habits.
3 Reasons Why Growth Investors Shouldn't Overlook Nu Skin (NUS)
by Zacks Equity Research
Nu Skin (NUS) possesses solid growth attributes, which could help it handily outperform the market.
5 Top Dividend Growth Stocks to Buy on the Cheap
by Sweta Killa
Honing in on stocks with a history of dividend growth leads to a healthy portfolio, with greater scope of capital appreciation as opposed to simple dividend-paying stocks or those with high yields.
Should Value Investors Buy Nu Skin Enterprises (NUS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NUS or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
New Strong Buy Stocks For November 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Inter Parfums (IPAR) Q3 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
Inter Parfums' (IPAR) third-quarter 2020 sales and earnings fall year over year. Nevertheless, results reflect sequential growth as stores reopened and e-commerce business was robust.
International Flavors (IFF) Q3 Earnings & Sales Lag Estimates
by Zacks Equity Research
International Flavors' (IFF) Fine Fragrance and Food Service categories witness declines due to the COVID-19 pandemic during the July-September quarter.
Coty (COTY) Up More Than 20% on Q1 Earnings & Sales Beat
by Zacks Equity Research
Coty's (COTY) first-quarter fiscal 2021 results reflect e-commerce strength and gains from innovation. Also, solid cost savings are a driver.
Nu Skin (NUS) Tops Q3 Earnings Estimates, Raises 2020 View
by Zacks Equity Research
Strong growth in sales leaders and customer base, as well as robust digital growth drive Nu Skin's (NUS) performance for third-quarter 2020.
Nu Skin Enterprises (NUS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 9.09% and -0.06%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Influence TreeHouse Foods' (THS) Q3 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) third-quarter 2020 results are likely to gain from increased demand and greater at-home consumption. However, high costs and a soft Food Away From Home business are concerning.
Here's How Flowers Foods (FLO) Looks Ahead of Q3 Earnings
by Zacks Equity Research
Strength in branded retail with Nature's Own, Canyon Bakehouse, Dave's Killer Bread and Wonder brands is likely to get reflected in Flowers Foods' (FLO) third-quarter performance.
How Prestige Consumer (PBH) Looks Just Ahead of Q2 Earnings
by Zacks Equity Research
Prestige Consumer's (PBH) second-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories. Nevertheless, robust cost curtailment efforts bode well.
Is Nu Skin Enterprises (NUS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Monster Beverage (MNST) Poised for an Earnings Beat in Q3?
by Zacks Equity Research
Monster Beverage (MNST) is likely to have gained from solid energy drinks business, improved at-home consumption trends and online demand in Q3. Cost leverage is likely to have aided earnings.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?